AR227194A1 - Procedimiento para la fabricacion de un preparado activador de la coagulacion de la sangre a base de proteinas humanas - Google Patents

Procedimiento para la fabricacion de un preparado activador de la coagulacion de la sangre a base de proteinas humanas

Info

Publication number
AR227194A1
AR227194A1 AR286129A AR28612981A AR227194A1 AR 227194 A1 AR227194 A1 AR 227194A1 AR 286129 A AR286129 A AR 286129A AR 28612981 A AR28612981 A AR 28612981A AR 227194 A1 AR227194 A1 AR 227194A1
Authority
AR
Argentina
Prior art keywords
procedure
manufacture
blood coagulation
human proteins
preparation based
Prior art date
Application number
AR286129A
Other languages
English (en)
Spanish (es)
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of AR227194A1 publication Critical patent/AR227194A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AR286129A 1980-07-22 1981-07-17 Procedimiento para la fabricacion de un preparado activador de la coagulacion de la sangre a base de proteinas humanas AR227194A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0378180A ATA378180A (de) 1980-07-22 1980-07-22 Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen

Publications (1)

Publication Number Publication Date
AR227194A1 true AR227194A1 (es) 1982-09-30

Family

ID=3555339

Family Applications (1)

Application Number Title Priority Date Filing Date
AR286129A AR227194A1 (es) 1980-07-22 1981-07-17 Procedimiento para la fabricacion de un preparado activador de la coagulacion de la sangre a base de proteinas humanas

Country Status (17)

Country Link
US (1) US4395396A (nl)
AR (1) AR227194A1 (nl)
AT (2) ATA378180A (nl)
BE (1) BE889640A (nl)
CH (1) CH646061A5 (nl)
DE (1) DE3127318A1 (nl)
DK (1) DK155500C (nl)
ES (1) ES504000A0 (nl)
FI (1) FI77048C (nl)
FR (1) FR2487199A1 (nl)
GB (1) GB2080312B (nl)
HU (1) HU188298B (nl)
IT (1) IT1142032B (nl)
LU (1) LU83499A1 (nl)
NL (1) NL190268C (nl)
NO (1) NO157245C (nl)
SE (1) SE460174B (nl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3473407D1 (en) * 1983-05-02 1988-09-22 Immuno Ag Method of inactivating pathogens
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
FR2622108B1 (fr) * 1987-10-23 1990-03-02 Lille Transfusion Sanguine Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
AU671586B2 (en) 1991-03-01 1996-09-05 Aventis Behring Llc Preparation of factor IX
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
FR2711371B1 (fr) * 1993-10-18 1995-12-29 Aetsrn Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
ATE296109T1 (de) * 1996-03-20 2005-06-15 Baxter Ag Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
CA2285935C (en) 1997-04-08 2011-01-18 Baxter Aktiengesellschaft An immunotolerant prothrombin complex preparation
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT411997B (de) 1999-09-14 2004-08-26 Baxter Ag Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
US7226615B2 (en) 2000-11-07 2007-06-05 Cryolife, Inc. Expandable foam-like biomaterials and methods
RS20050051A (en) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity
DE50311422D1 (de) * 2002-07-23 2009-05-28 Bio & Bio Licensing Sa Thrombingenerierfähige und thrombinhaltige pharmazeutische wirkstoffzubereitungen und arzneimittel
US7297336B2 (en) 2003-09-12 2007-11-20 Baxter International Inc. Factor IXa specific antibodies displaying factor VIIIa like activity
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492108A1 (de) 1964-05-04 1969-10-02 Rohm & Haas Verfahren zur Entfernung von Viren aus Blut waehrend der Entnahme oder UEbertragung
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
JPS52125609A (en) 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
US4081432A (en) 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
WO1981002105A1 (en) * 1980-01-28 1981-08-06 Baxter Travenol Lab Therapeutic compositions & methods for manufacture and use
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them

Also Published As

Publication number Publication date
IT1142032B (it) 1986-10-08
CH646061A5 (de) 1984-11-15
FR2487199B1 (nl) 1984-11-16
DK318581A (da) 1982-01-23
GB2080312B (en) 1983-12-21
BE889640A (fr) 1981-11-03
NL190268C (nl) 1994-01-03
NO157245C (no) 1988-02-24
NO157245B (no) 1987-11-09
LU83499A1 (de) 1981-10-29
FI77048B (fi) 1988-09-30
FI812295L (fi) 1982-01-23
DE3127318A1 (de) 1982-04-15
ATA378180A (de) 1982-04-15
SE460174B (sv) 1989-09-18
IT8123070A0 (it) 1981-07-22
NL190268B (nl) 1993-08-02
SE8103759L (sv) 1982-01-23
DK155500B (da) 1989-04-17
ES8203610A1 (es) 1982-04-16
GB2080312A (en) 1982-02-03
US4395396A (en) 1983-07-26
NO812500L (no) 1982-01-25
AT368883B (de) 1982-11-25
ES504000A0 (es) 1982-04-16
NL8103329A (nl) 1982-02-16
HU188298B (en) 1986-03-28
DK155500C (da) 1989-08-07
FI77048C (fi) 1989-01-10
FR2487199A1 (fr) 1982-01-29
DE3127318C2 (nl) 1988-07-28

Similar Documents

Publication Publication Date Title
AR227194A1 (es) Procedimiento para la fabricacion de un preparado activador de la coagulacion de la sangre a base de proteinas humanas
AR227252A1 (es) Procedimiento para la fabricacion de un aglutinante para tejidos a base de proteinas humanas o animales
MX159208A (es) Procedimiento para la fabricacion de suturas quirurgicas mejoradas
ES501017A0 (es) Dispositivo para la aplicacion de un aglutinante de tejido abase de proteinas humanas o animales
ES547139A0 (es) Procedimiento para preparar una proteina inhibidora de la coagulacion de la sangre
DK268187D0 (da) Intraokulaert kirurgisk instrument
ES504716A0 (es) Procedimiento para la preparacion de catalizadores para la polimerizacion de alfa-olefinas
AR222209A1 (es) Procedimiento para la obtencion de un aglutinante para los tejidos,a base de proteinas humanas o animales,con un contenido de fibrinogeno y de factor xiii
BR8404890A (pt) Grampeador cirurgico linear descartavel
BR8402948A (pt) Montagem de lanceta descartavel para sangue
AR213861A1 (es) Un procedimiento para la obtencion de un preparado fomentador de la coagulacion de la sangre
ES543559A0 (es) Procedimiento para la preparacion de activadores de plasmi- nogeno de tejidos
MX163269B (es) Procedimiento para la polimerizacion en masa de diciclopentadieno
AR223422A1 (es) Procedimiento para la confeccion normalizada de calzados
ES500259A0 (es) Procedimiento para la preparacion de fosfolipidos polimeros
IT1203671B (it) Reagente per la determinazione del la funzione di coagulazione del sangue e procedimento per la sua preparazione
ES486698A0 (es) Mejoras introducidas en la fabricacion de suturas quirurgi- cas elastomericas
ES529981A0 (es) Procedimiento para la extraccion y la recogida higienicas de sangre de animales
IT1070822B (it) Procedimento per la fabbricazione di cuoio artificiale a contenuto proteico
KR850000218U (ko) 일회용 검사 혈액형
ES492109A0 (es) Procedimiento para hacer digeribles las proteinas queratino-sas y las globulares de la sangre
ES537299A0 (es) Procedimiento para la fabricacion de un gel de colageno
ES499510A0 (es) Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos
ES267569Y (es) "conjunto para la practica de analisis clinicos".
IT1193418B (it) Strumento chirurgico monouso